Genomic Analyses Uncover Evolutionary Features of Influenza A/H3N2 Viruses in Yunnan Province, China, from 2017 to 2022

Meiling Zhang,Jienan Zhou,Ruize Ni,Xiaonan Zhao,Yaoyao Chen,Yanhong Sun,Zhaosheng Liu,Xiaoyu Han,Chunrui Luo,Xiaoqing Fu,Yong Shao
DOI: https://doi.org/10.3390/v16010138
2024-01-19
Viruses
Abstract:Influenza A viruses evolve at a high rate of nucleotide substitution, thereby requiring continuous monitoring to determine the efficacy of vaccines and antiviral drugs. In the current study, we performed whole-genome sequencing analyses of 253 influenza A/H3N2 strains from Yunnan Province, China, during 2017–2022. The hemagglutinin (HA) segments of Yunnan A/H3N2 strains isolated during 2017–2018 harbored a high genetic diversity due to heterogeneous distribution across branches. The mutation regularity of the predominant antigenic epitopes of HA segments in Yunnan was inconsistent in different years. Some important functional mutations in gene segments associated with viral adaptation and drug tolerance were revealed. The rapid genomic evolution of Yunnan A/H3N2 strains from 2017 to 2022 mainly concentrated on segments, i.e., matrix protein 2 (M2), non-structural protein 1 (NS1), neuraminidase (NA), NS2, and HA, with a high overall non-synonymous/synonymous substitution ratio (dN/dS). Our results highlighted a decline in vaccine efficacy against the A/H3N2 circulating strains, particularly against the Yunnan 2021–2022 A/H3N2 strains. These findings aid our understanding of evolutionary characteristics and epidemiological monitoring of the A/H3N2 viruses and provide in-depth insights into the protective efficacy of influenza vaccines.
virology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to reveal the evolutionary characteristics of influenza A/H3N2 virus strains prevalent in Yunnan province, China from 2017 to 2022 through genomic analysis. Specifically, the study aims to: 1. **Evaluate genetic diversity**: Analyze the genetic diversity of A/H3N2 virus strains in Yunnan province from 2017 to 2022, especially the genetic diversity of the hemagglutinin (HA) segment. 2. **Explore antigenic drift**: Study the mutation rules of the main antigenic epitopes of the A/H3N2 virus and their changes in different years. 3. **Identify important functional mutations**: Reveal important functional mutations in gene segments related to virus adaptability and drug tolerance. 4. **Evaluate vaccine efficacy**: Evaluate the protective efficacy of vaccines against currently prevalent A/H3N2 virus strains, especially the effect from 2021 to 2022, by comparing the antigenic distance between vaccine strains and epidemic strains. 5. **Provide epidemiological surveillance**: Provide in - depth insights for the epidemiological surveillance of influenza viruses through the study of the evolutionary characteristics of these viruses, and help understand the protective efficacy of influenza vaccines. Through these research objectives, the authors hope to provide a scientific basis for the prevention and control of influenza viruses, especially for the vaccine development and use strategies of A/H3N2 virus strains.